In silico chemical screening identifies epidermal growth factor receptor as a therapeutic target of drug-tolerant CD44v9-positive gastric cancer cells

Por Mashima, Tetsuo, Iwasaki, Risa, Kawata, Naomi, Kawakami, Ryuhei, Kumagai, Koshi, Migita, Toshiro, Sano, Takeshi, Yamaguchi, Kensei, Seimiya, Hiroyuki
Publicado no Br J Cancer (2019)

ALDH1A3‐mTOR axis as a therapeutic target for anticancer drug‐tolerant persister cells in gastric cancer

Por Kawakami, Ryuhei, Mashima, Tetsuo, Kawata, Naomi, Kumagai, Koshi, Migita, Toshiro, Sano, Takeshi, Mizunuma, Nobuyuki, Yamaguchi, Kensei, Seimiya, Hiroyuki
Publicado no Cancer Sci (2020)

Serum VEGF-A and CCL5 levels as candidate biomarkers for efficacy and toxicity of regorafenib in patients with metastatic colorectal cancer

Por Suenaga, Mitsukuni, Mashima, Tetsuo, Kawata, Naomi, Wakatsuki, Takeru, Horiike, Yuki, Matsusaka, Satoshi, Dan, Shingo, Shinozaki, Eiji, Seimiya, Hiroyuki, Mizunuma, Nobuyuki, Yamaguchi, Kensei, Yamaguchi, Toshiharu
Publicado no Oncotarget (2016)